1. Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma. (8th September 2021) Authors: Foureau, David; Bhutani, Manisha; Guo, Fei; Rigby, Katherine; Leonidas, Marina; Tjaden, Elise; Fox, Andee; Atrash, Shebli; Paul, Barry; Voorhees, Peter M.; Usmani, Saad Z. Journal: Cancer medicine Issue: Volume 10:Number 20(2021) Page Start: 6933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 10281 (3rd April 2021) Authors: Lockman, Shahin; Brummel, Sean S; Ziemba, Lauren; Stranix-Chibanda, Lynda; McCarthy, Katie; Coletti, Anne; Jean-Philippe, Patrick; Johnston, Ben; Krotje, Chelsea; Fairlie, Lee; Hoffman, Risa M; Sax, Paul E; Moyo, Sikhulile; Chakhtoura, Nahida; Stringer, Jeffrey SA; Masheto, Gaerolwe; Korutaro, Vi... Journal: Lancet Issue: Volume 397:Issue 10281(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗